131 related articles for article (PubMed ID: 1394221)
41. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.
Ghose T; Blair AH
J Natl Cancer Inst; 1978 Sep; 61(3):657-76. PubMed ID: 80453
[TBL] [Abstract][Full Text] [Related]
42. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.
Burrows FJ; Thorpe PE
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8996-9000. PubMed ID: 7692443
[TBL] [Abstract][Full Text] [Related]
43. Primitive endothelial cell lines from the porcine embryonic yolk sac.
Plendl J; Gilligan BJ; Wang SJ; Lewis R; Shinners B; Vandenbroeck K; Auerbach R
In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):334-42. PubMed ID: 12513121
[TBL] [Abstract][Full Text] [Related]
44. Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23).
Wakai Y; Matsui J; Koizumi K; Tsunoda S; Makimoto H; Ohizumi I; Taniguchi K; Kaiho S; Saito H; Utoguchi N; Tsutsumi Y; Nakagawa S; Ohsugi Y; Mayumi T
Jpn J Cancer Res; 2000 Dec; 91(12):1319-25. PubMed ID: 11123432
[TBL] [Abstract][Full Text] [Related]
45. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.
Burrows FJ; Derbyshire EJ; Tazzari PL; Amlot P; Gazdar AF; King SW; Letarte M; Vitetta ES; Thorpe PE
Clin Cancer Res; 1995 Dec; 1(12):1623-34. PubMed ID: 9815965
[TBL] [Abstract][Full Text] [Related]
46. Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B.
Li HK; Hasegawa S; Nakajima NI; Morokoshi Y; Minegishi K; Nagatsu K
Biochem Biophys Res Commun; 2018 Dec; 506(4):1078-1084. PubMed ID: 30409432
[TBL] [Abstract][Full Text] [Related]
47. Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo.
Reid GS; Shan X; Coughlin CM; Lassoued W; Pawel BR; Wexler LH; Thiele CJ; Tsokos M; Pinkus JL; Pinkus GS; Grupp SA; Vonderheide RH
Clin Cancer Res; 2009 Nov; 15(21):6602-8. PubMed ID: 19825945
[TBL] [Abstract][Full Text] [Related]
48. Identification of tumor vascular antigens by monoclonal antibodies prepared from rat-tumor-derived endothelial cells.
Ohizumi I; Tsunoda S; Taniguchi K; Saito H; Esaki K; Koizumi K; Makimoto H; Wakai Y; Matsui J; Tsutsumi Y; Nakagawa S; Utoguchi N; Ohsugi Y; Mayumi T
Int J Cancer; 1998 Aug; 77(4):561-6. PubMed ID: 9679759
[TBL] [Abstract][Full Text] [Related]
49. Expression of Ia antigen on vascular endothelial cells in mouse cerebral tissue grafted into the third ventricle of rat brain.
Kohsaka S; Shinozaki T; Nakano Y; Takei K; Toya S; Tsukada Y
Brain Res; 1989 Apr; 484(1-2):340-7. PubMed ID: 2785429
[TBL] [Abstract][Full Text] [Related]
50. [Targeting therapy using a monoclonal antibody against tumor vascular endothelium].
Tsunoda S; Tsutsumi Y; Nakagawa S; Mayumi T
Yakugaku Zasshi; 2000 Mar; 120(3):256-64. PubMed ID: 10723267
[TBL] [Abstract][Full Text] [Related]
51. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues.
Wang JM; Kumar S; Pye D; van Agthoven AJ; Krupinski J; Hunter RD
Int J Cancer; 1993 May; 54(3):363-70. PubMed ID: 8509210
[TBL] [Abstract][Full Text] [Related]
52. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy.
Ran S; Thorpe PE
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1479-84. PubMed ID: 12459374
[TBL] [Abstract][Full Text] [Related]
53. Vascular targeting--a new approach to the therapy of solid tumors.
Burrows FJ; Thorpe PE
Pharmacol Ther; 1994 Oct; 64(1):155-74. PubMed ID: 7846113
[TBL] [Abstract][Full Text] [Related]
54. Development of Antibody-Based Vaccines Targeting the Tumor Vasculature.
Zhuang X; Bicknell R
Methods Mol Biol; 2016; 1403():839-49. PubMed ID: 27076170
[TBL] [Abstract][Full Text] [Related]
55. Suppression of solid tumor growth by a monoclonal antibody against tumor vasculature in rats: involvement of intravascular thrombosis and fibrinogenesis.
Ohizumi I; Taniguchi K; Saito H; Kawata H; Tsunoda S; Makimoto H; Wakai Y; Tsutsumi Y; Nakagawa S; Utoguchi N; Kaiho S; Ohsugi Y; Mayumi T
Int J Cancer; 1999 Sep; 82(6):853-9. PubMed ID: 10446453
[TBL] [Abstract][Full Text] [Related]
56. Nude mouse interim host model for human parathyroid grafts. II. Alteration of MHC antigens in human PTG grafts in the nude mouse.
Gao Z; Zhu Y; Yao C; Li D; Han S
Chin Med Sci J; 1992 Jun; 7(2):95-7. PubMed ID: 1450400
[TBL] [Abstract][Full Text] [Related]
57. Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy.
Molema G; de Leij LF; Meijer DK
Pharm Res; 1997 Jan; 14(1):2-10. PubMed ID: 9034214
[TBL] [Abstract][Full Text] [Related]
58. Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats.
Ohizumi I; Tsunoda S; Taniguchi K; Saito H; Esaki K; Makimoto H; Wakai Y; Tsutsumi Y; Nakagawa S; Utoguchi N; Kaiho S; Ohsugi Y; Mayumi T
Biochem Biophys Res Commun; 1997 Jul; 236(2):493-6. PubMed ID: 9240467
[TBL] [Abstract][Full Text] [Related]
59. An address system in the vasculature of normal tissues and tumors.
Ruoslahti E; Rajotte D
Annu Rev Immunol; 2000; 18():813-27. PubMed ID: 10837076
[TBL] [Abstract][Full Text] [Related]
60. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer.
Rettig WJ; Garin-Chesa P; Healey JH; Su SL; Jaffe EA; Old LJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10832-6. PubMed ID: 1438285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
